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The central nervous system (CNS) barriers are highly specialized cellular barriers that
promote brain homeostasis while restricting pathogen and toxin entry. The primary
cellular constituent regulating pathogen entry in most of these brain barriers is the
brain endothelial cell (BEC) that exhibits properties that allow for tight regulation of CNS
entry. Bacterial meningoencephalitis is a serious infection of the CNS and occurs when
bacteria can cross specialized brain barriers and cause inflammation. Models have been
developed to understand the bacterial – BEC interaction that lead to pathogen crossing
into the CNS, however, these have been met with challenges due to these highly
specialized BEC phenotypes. This perspective provides a brief overview and outlook of
the in vivo and in vitro models currently being used to study bacterial brain penetration,
and opinion on improved models for the future.
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THE BRAIN BARRIERS
The brain barriers are comprised of a number of endothelial and epithelial cellular barriers that
serve to maintain brain homeostasis and prevent pathogen entry into the central nervous system
(CNS; Engelhardt and Sorokin, 2009; Abbott et al., 2010; Redzic, 2011). These barriers are especially
adept at regulating nutrients and molecules passage into the CNS, while at the same time restricting
access to many xenobiotic drugs and pathogens (Engelhardt and Sorokin, 2009; Abbott et al., 2010;
Redzic, 2011; Spindler and Hsu, 2012; Doran et al., 2016). In the average adult human, the total
cerebral microvasculature has been estimated at a total surface area of 15–25 m2, and a total length
of around 600 km (Zlokovic, 2005; Wong et al., 2013). The endothelial blood–brain barrier (BBB)
makes up the majority of the brain microvasculature and is the primary location for exchange
processes between the circulation and CNS (Redzic, 2011). The BBB is supported by a number of
other cell types, such as astrocytes, pericytes, and neurons [collectively called the neurovascular unit
(NVU)], that not only enhance barrier properties, but also regulate the ability of the endothelial cell
to transport essential nutrients into the CNS and discharge metabolic products from the CNS into
the blood (Abbott et al., 2010). The endothelium of the BBB possesses barrier properties different
than other vascular networks elsewhere in the body, and these phenotypes contribute to their
ability to function. The meningeal blood-cerebral spinal fluid barrier (mBCSFB) is an additional
endothelial barrier comprised of brain vessels with similar properties to the BBB, although not
supported by the NVU and associated cell types. Instead, the endothelium of the mBCSFB is
surrounded by cerebral spinal fluid (CSF), and can be closely associated with leptomeningeal cells
Frontiers in Microbiology | www.frontiersin.org 1 June 2019 | Volume 10 | Article 1336
fmicb-10-01336 June 13, 2019 Time: 15:26 # 2
Kim et al. Modeling Bacterial–Blood–Brain Barrier Interactions
(Rua and McGavern, 2018). An important epithelial brain barrier
can be found in the choroid plexus (CP) where the capillaries are
more similar to those of the peripheral endothelium exhibiting
fenestrations and do not form a barrier, instead a single layer
of specialized epithelial cells forms the barrier phenotype of
the CP. These epithelial cells are the principle component of
what is known as the blood-CSF barrier (BCSFB; Engelhardt
and Sorokin, 2009). One of the major phenotypes that describe
each of these brain barriers is the presence of tight junctions
that seal adjacent cells to one another, and represent a distinctive
barrier phenotype of the brain barriers (Engelhardt and Sorokin,
2009). The tight junctions are formed by a host of transmembrane
proteins including occludin, ZO-1 and claudin-5 (Nitta et al.,
2003). To cause serious CNS infection, infectious agents such
as bacteria, viruses, and parasites, must cross or subvert
these brain barriers.
Bacterial meningoencephalitis is a serious infection of the
CNS and is uniformly fatal if left untreated. Certain bacteria that
cause meningoencephalitis have the ability to interact with and
penetrate one or more of the brain barriers allowing access to
the CNS and causing inflammation. This perspective outlines
models utilized to examine bacterial pathogen–brain barrier
studies, and discusses the incorporation of novel barrier models
with particular focus on the endothelial barriers of the CNS and
the key bacterial pathogens associated with meningoencephalitis
and CNS disease.
BACTERIAL PATHOGENS ASSOCIATED
WITH CNS DISEASE
There are a number of bacterial pathogens capable of interacting
with and penetrating brain endothelial cells (BECs) to gain
access to the CNS and cause meningoencephalitis. Neisseria
meningitidis (meningococcus) and Streptococcus pneumoniae
(pneumococcus) are leading causes of meningoencephalitis
in young adults and the elderly (Doran et al., 2016; Coureuil
et al., 2017). N. meningitidis is a leading cause of epidemic
meningococcal meningoencephalitis in the “meningitis belt” of
sub-Saharan Africa and developing nations, but remains a health
threat in the developed world (Doran et al., 2016; Schubert-
Unkmeir, 2017). Streptococcus pneumonaie (pneumococcus)
remains a common cause of bacterial meningoencephalitis
despite the development of multivalent vaccines (Feikin
et al., 2013; Doran et al., 2016). Meningeal pathogens
that affect the newborn include Streptococcus agalactiae,
commonly known as Group B Streptococcus (GBS), and
Escherichia coli K1. GBS is the leading cause of neonatal
meningoencephalitis and can be vertically transmitted from
mother to newborn during the birthing process (Doran and
Nizet, 2004). While prophylactic antibiotic treatment has
limited maternal GBS colonization and transmission to the
newborn, treatment has had little impact on the incidence of
GBS meningoencephalitis (Berardi et al., 2013). E. coli K1 is
the second leading cause of neonatal meningoencephalitis.
While modern antibiotic treatments have reduced mortality,
complications remain due to the amount of endotoxin that
remains from dead bacteria resulting in septic shock (Shenep
and Mogan, 1984; Doran et al., 2016). Some additional
bacterial pathogens may under specific conditions or in certain
hosts cause CNS disease, such as Listeria monocytogenes,
Mycobacterium tuberculosis, Streptococcus suis, Salmonella
spp., Klebsiella spp., and Staphylococcus aureus. In general,
many of these pathogens can persist in the human as a
normal colonizer of mucosal surfaces. However, in certain
cases can enter the blood stream, replicate to high levels, and
interact with brain barriers where they may gain access to
the CNS (Doran et al., 2016). Presently various models to
understand how these pathogens enter the CNS have been
employed and better appropriations of cellular brain barriers are
being developed.
IN VIVO MODELS USED TO STUDY
BRAIN PENETRATION AND CNS
DISEASE
To elucidate mechanisms of penetration of the BBB by pathogens
in the context of live organisms, researchers utilize in vivo
models of CNS transit and pathology. These models have the
advantage of possessing intact brain barriers, and are conducted
in the context of a competent immune system. Much work has
been done to elucidate mechanisms of BBB dysfunction during
infection using mouse, rat, rabbit, and zebrafish models, and each
model has distinct advantages and disadvantages. Identifying
in vivo mechanisms of brain barrier traversal is a critical step in
understanding the pathogenesis of many meningeal pathogens.
Rodent models have been widely utilized to study bacterial
meningoencephalitis, specifically the mouse and rat. Typically,
these models can be distinguished mainly by the route of
injection. Direct infection of the CNS through intra-cerebral
or intra-cisternal route allows for the monitoring of host–
pathogen interactions once the pathogen is in the CNS
as well as leukocyte transmigration (Shapiro et al., 2000;
Koedel et al., 2001; Grandgirard et al., 2007; Reiß et al.,
2011; Koopmans et al., 2018). While this method is useful,
it lacks a more natural course of dissemination through
the blood stream (Chiavolini et al., 2008). To this end,
hematogenous routes have been employed introducing bacteria
via intraperitoneal, intravenous, or intracardiac injections.
This route allows for the development of bacteriemia prior
to crossing of the brain barriers and better models a
blood to CNS transit of bacteria (Ferrieri et al., 1980; Kim
et al., 1992, 2015a; Tan et al., 1995; Hoffman et al., 2000;
Wang and Kim, 2002; Liu et al., 2004; Doran et al., 2005;
Banerjee et al., 2010). Alternate routes of infection leading
to meningoencephalitis have been utilized such as intranasal
administration of bacteria (Ferrieri et al., 1980; Zwijnenburg
et al., 2001; Mittal et al., 2010, 2011). This method can be
especially useful when examining a pathogen that typically
colonizes the nasopharynx and surrounding tissue such as
with S. pneumoniae (Zwijnenburg et al., 2001). In the case of
food-borne pathogens, such as L. monocytogenes, intragastric
infection can be useful to mimic disease (Lecuit et al., 2001;
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Maury et al., 2016). Recently, an interesting mouse model
for GBS infection was employed that relied on a colonized
mother passing along GBS to neonates vertically as it is
hypothesized to take place in human infection (Andrade
et al., 2018). While extremely useful and widely used, rodent
models have their limitations especially when it comes to
pathogens such as L. monocytogenes and N. meningitidis which
are primarily human specific pathogens. In order to model
disease with these pathogens, transgenic mice which express
specific human genes or humanized mice are often utilized
which limits the scope of the interactions that may be studied
(Mackinnon et al., 1992; Lecuit et al., 2001; Yi et al., 2003;
Zarantonelli et al., 2007; Johswich et al., 2013; D’Orazio, 2014;
Maury et al., 2016).
In addition to rodent models, other in vivo systems have been
developed to study bacterial penetration of brain barriers and
progression of meningoencephalitis. The zebrafish (Danio rerio)
has certain advantages such as high group numbers, optically
clear, and genetically tractable. In recent years zebrafish have
been used to model brain barrier crossing or meningoencephalitis
for Mycobacterium, GBS, S. pneumoniae, and Streptococcus
iniae (Patterson et al., 2012; Harvie et al., 2013; van Leeuwen
et al., 2014; Kim et al., 2015a,b; Jim et al., 2016). Interestingly
pathogens like S. iniae and GBS are zoonotic pathogens
impacting fish in aquaculture with pathology similar to humans,
as it can cause meningoencephalitis in fish (Delannoy et al.,
2013; Wang et al., 2017; Mishra et al., 2018). Thus, the
zebrafish model presents an interesting method to examine
bacterial pathogenesis in fish as well to improve aquaculture
methods. However, it is important to note that the zebrafish
BBB differs from the mammalian BBB particularly due to the
lack of true astrocytes, instead they possess a different glial
cell type that serves a similar purpose (O’Brown et al., 2018).
Other less common mammalian models include the rabbit,
guinea pig, and the gerbil to model meningoencephalitis in a
wide range of pathogens (Michael Scheld et al., 1979; Sinai
et al., 1980; Sulc et al., 1992; Zysk et al., 1996; Blanot et al.,
1997; Tauber, 1998; Marra and Brigham, 2001; Chiavolini
et al., 2008; D’Orazio, 2014; Tucker et al., 2016). In certain
cases, non-human primates have been used and demonstrate
natural meningoencephalitis, especially with L. monocytogenes
(Kaufmann and Quist, 1969; Mook-kanamori et al., 2011; Lemoy
et al., 2012; Scanga and Flynn, 2014). However, these models
are often cost and facilities-prohibitive and difficult to get
approved due to institutional restrictions. Each in vivo model
offers specific advantages and/or disadvantages and selection of
models may come down to availability and usefulness to the
research question.
THE USE OF IN VITRO MODELS OF
ENDOTHELIAL BRAIN BARRIERS
DURING INFECTION
In vitro models comprised of human BECs eliminate some
of the pitfalls from the in vivo models such as interspecies
TABLE 1 | Comparison of in vitro BEC models.
Model Type TEER
( × cm2)
Tight junctions Bacterial pathogens
studied
Model origin
(year)
References
hBMEC Human immortalized by
SV40 large T antigen
20 to 40 ZO-1 and Occludin
present. Claudin-5
absent
S. pneumoniae,
S. agalactiae, E. coli Kl,
L. monocytogenes,
N. meningitidis, B. abortus,
C. freundii, and others
1997 Badger et al., 1999;
Banerjee et al., 2010;
Doran et al., 2005;
Eigenmann et al., 2013;
Greiffenberg et al.,
1998; Helms et al.,
2015; Hoffman et al.,
2000; Badger et al.,
2002; Miraglia et al.,
2018; Nizet et al.,
1997; Stins et al., 2001;
Uchiyama et al., 2009
hCMEC/D3 Human immortalized by
SV40 large T antigen
and hTERT
10 to 200 ZO-1, Occludin, and
Claudin-5 present
N. meningitidis,
S. agalactiae,
S. pneumoniae, S. suis
2005 Bernard et al., 2014;
Coureuil et al., 2010;
Deng et al., 2018;
Eigenmann et al., 2013;
Helms et al., 2015;
Jiménez-Munguía et al.,
2018; Wang et al.,
2015; Weksler et al.,
2005
iPSC-derived
BECs
Human stem-cell
derived
250 to 5000+ ZO-1, Occludin, and
Claudin-5 present and
localized to cell-cell
junctions
S. agalactiae,
N. meningitidis
2012 Gomes et al., 2019;
Helms et al., 2015;
Hollmann et al., 2017;
Kim et al., 2017;
Lippmann et al., 2012,
2014; Qian et al., 2017;
Stebbins et al., 2016
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FIGURE 1 | Schematic diagrams of iPSC-derived BEC models and co-culture. (A) Derivation of iPSC-derived BECs adapted from Lippmann et al. (2012). Overall the
13-day process results in purified iPSC-derived BECs. Day-3 to 0 iPSCs are expanded in TesR1 media. Day 0–6, cells are differentiated in unconditioned media
(UM). Days 6–9, endothelial cells are expanded using endothelial cell (EC) media supplemented with basic fibroblast growth factor (bFGF), and retinoic acid (RA). On
day 8 endothelial cells are purified onto a collagen/fibronectin matrix. Day 9 cells get a final change into EC media. (B) Schematic GBS infection of iPSC-BECs as
described in Kim et al. (2017). B1, demonstrated that GBS can interact with iPSC-BECs by adherence, invasion, and intracellular survival. B2, GBS mutants are
attenuated for iPSC-BEC interaction. B3, GBS induces the tight junction repressor Snail1 previously shown to contribute to the destruction of tight junctions. B4,
innate immune activation is seen through the upregulation of cytokines and chemokines. (C) Potential transwell model combinations in co-culture with iPSC-derived
BECs with other cell types of the CNS such as astrocytes (orange), neurons (blue), pericytes (purple), and leptomeningeal cells (green).
differences, scalability, and availability (Syvänen et al., 2009;
Warren et al., 2009; Lippmann et al., 2012). One of the first
immortalized cell lines utilized for study of bacterial BEC
interaction was the human brain microvascular endothelial
cell (hBMEC) line. Cells were initially isolated from a patient
with epilepsy and then immortalized by the transformation
with SV40 large T-antigen (Nizet et al., 1997). The hBMEC line
has been used widely for the determination of bacterial-BEC
interactions with bacterial pathogens such as S. pneumoniae,
GBS, N. meningitidis, E. coli K1, L. monocytogenes, and
others (Nizet et al., 1997; Greiffenberg et al., 1998; Badger
et al., 1999, 2002; Hoffman et al., 2000; Stins et al., 2001;
Doran et al., 2005; Uchiyama et al., 2009; Banerjee et al., 2010;
Miraglia et al., 2018). While this model has been used successfully
over the years for mechanistic studies, it has some limitations
including the lack of certain BEC key characteristics such as
continuous tight junction staining and claudin-5 expression
(Table 1; Kim et al., 2017). Other immortalized BECs such as
hCMEC/D3 have been developed by transforming microvessels
isolated from an epileptic patient, with hTERT and SV40
(Weksler et al., 2005). This model has been employed to
examine interactions with various infectious agents ranging
from bacteria, viruses, fungi, and parasites (Coureuil et al.,
2010; Bernard et al., 2014; N’Dilimabaka et al., 2014; Volle
et al., 2015; Wang et al., 2015; Mutso et al., 2017; Aaron
et al., 2018; Deng et al., 2018; Jiménez-Munguía et al., 2018).
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The hCMEC/D3 model better recapitulates more phenotypes
of BECs, such as claudin-5 expression, however, they still
do not localize certain tight junction components and
produce relatively low transendothelial electrical resistance
(TEER), indicative of suboptimal barrier function (Weksler,
2005; Eigenmann et al., 2013). Each in vitro model using
primary or immortalized BECs has differing attributes
that must be carefully assessed depending on envisioned
application, and a comprehensive review can be found elsewhere
(Helms et al., 2015).
IMPROVED IN VITRO MODELS AND
FUTURE OUTLOOKS
As mentioned above, many of the primary and immortalized BBB
models lack critical BEC phenotypes limiting their usefulness
(Helms et al., 2015). This highlights the challenge of modeling
human BECs in vitro, as many of the models may lack key
BBB properties. Primary cells may have low availability and once
removed from the brain microenvironment, lose phenotypes
associated with BECs (Lippmann et al., 2012; Helms et al.,
2015). Additionally while immortalized BECs are highly scalable,
they only offer a facile model and often lack continuous
tight junctions and appropriate barrier function (Table 1;
Lippmann et al., 2013; Helms et al., 2015; Rahman et al.,
2016). In our opinion, recent advances in stem cell-based
technologies offer the prospects of superior BBB modeling.
These human stem cell-derived BECs possess expected markers,
functional transporters, and continuous tight junction staining
corresponding to the high TEER values (Table 1; Lippmann
et al., 2012, 2014; Cecchelli et al., 2014; Stebbins et al.,
2016; Hollmann et al., 2017; Qian et al., 2017). Using human
induced pluripotent stem cells (iPSCs), BECs can be generated
without the requirement of co-culture with other NVU cell
types, and iPSC sources offer the added benefit of being easily
scalable (Lippmann et al., 2012, 2014). Figure 1A provides
an example of one differentiation process to achieve BECs
from iPSC sources that has been utilized (Lippmann et al.,
2012, 2014). The iPSC model has been used to examine drug
delivery, genetic human disease and ischemic stroke (Clark
et al., 2016; Vatine et al., 2016; Kokubu et al., 2017; Lim et al.,
2017), but only recently has it been evaluated for the study
of microbe interactions. It was shown that GBS adhere to,
invade, and activate the iPSC-derived BECs, while GBS mutants
known to have diminished BBB interaction were attenuated
in the iPSC-derived model (Figure 1B; Kim et al., 2017).
GBS infection also resulted in the disruption of tight junction
components, ZO-1, Occludin, and Claudin-5 (Figure 1B).
Furthermore, it was shown that a mechanism of GBS destruction
of tight junctions through the Snail1 transcription factor was
consistent in the iPSC-BEC model (Kim et al., 2017). While
this mechanism was first shown using GBS, recently another
meningeal pathogen, E. coli K1, has been found to induce
Snail1 (Kim et al., 2015a; Yang et al., 2016). We anticipate
that this mechanism of tight junction disruption may be
utilized by other pathogens, and the iPSC-BEC model, with
superior tight junction and barrier function would be an ideal
system for conducting these studies. This demonstrates that
the iPSC-derived BBB model can be utilized to study BBB
interaction with bacterial CNS pathogens, and has the potential
to be expanded to other pathogens. Interestingly, researchers
have used iPSC-derived BECs to demonstrate that Zika virus
can cross BECs without disrupting the junctions (Alimonti
et al., 2018). A recent proof of principle publication showed
that iPSC-BECs can also model interactions with the human
specific N. meningitidis (Gomes et al., 2019). Thus, human
iPSC-derived BEC models hold promise for further study of
human specific pathogens, particularly those that lack robust
in vivo models.
Advances in biological engineering have also paved the
way for the modeling of other aspects of the brain barriers
such as shear stress to mimic blood flow, and co-culture with
supporting cell types of the NVU (e.g., astrocytes, pericytes,
and leptomeningeal cells). BECs respond to cues from NVU by
enhancing BBB phenotypes such as TEER, and tight junctions.
Co-culture models have utilized the Transwell system and
demonstrated enhanced properties with stem cell derived ECs
and BECs. (Lippmann et al., 2012; Cecchelli et al., 2014;
Appelt-Menzel et al., 2017; Canfield et al., 2017). It would
thus be possible to model bacterial interaction during co-
culture with enhanced BBB properties and potential cross talk
between cells (Figure 1C). Direct interactions with glial cell
types such as astrocytes and microglia have been explored,
and in general it appears that glial cells respond by secreting
cytokines and chemokines (Cooley et al., 2014; Stoner et al.,
2015; Seele et al., 2016). Additionally, interactions at the mBCSFB
would occur between bacteria and BECs that are supported
by leptomeningeal cells, nevertheless until now only direct
interactions with a cancerous leptomeningeal cell line have been
investigated (Fowler et al., 2004; Alkuwaity et al., 2012). While
responses of these other brain residing cell types have been
established, little has been done to determine the impact of the
other brain cell types in co-culture with BECs during infection
(Figure 1C). Presently, work is being conducted to model the
3-dimentional blood vessel, and presents an opportunity for
the incorporation of the natural vessel architecture (Adriani
et al., 2015; Cho et al., 2015). These models take advantage
of using flow and multicellularity while retaining the overall
structure of a blood vessel. It will be of great interest to the
field to understand the contribution of these other CNS cell
types and architecture, to host–pathogen interaction and overall
maintenance of barrier integrity during infection. Establishing
multi-cellular in vitro systems that include high barrier forming
endothelial cells, such as the iPSC-BECs, will expand our
understanding of the host–pathogen interface at brain barriers
and CNS infectious disease.
CONCLUSION
Challenges in modeling host–pathogen interaction at the brain
barriers have led to a variety of models both in vitro and in vivo.
While in vivo models inherently have interspecies variations,
Frontiers in Microbiology | www.frontiersin.org 5 June 2019 | Volume 10 | Article 1336
fmicb-10-01336 June 13, 2019 Time: 15:26 # 6
Kim et al. Modeling Bacterial–Blood–Brain Barrier Interactions
widely used in vitro models of BECs generally lack robust
BBB-like properties. We believe that an iPSC-derived BEC
model may prove useful especially when high barrier function is
required, or when a human-specific pathogen is used that lacks
good in vivo models.
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